In 2015, Jackie Nixon was diagnosed with Stage 1 lung cancer and her subsequent investigation discovered high levels of radon in her condominium building. The revelation was the pivot point to her joining Citizens Radioactive Radon Reduction (CR3) and creating and marketing the international radon publication, CR3 News Magazine, to communicate the cancer risks associated with radon.
View Jackie's Story
She has shared her experiences and knowledge of the danger of radon at the International Radon Symposium hosted by American Association of Radon Scientists and Technologists, at regional EPA Stakeholders meetings, LungCAN and LungForce, as well as videos for the CDC, PA DEP and the AllOfUs Program. She has presented at many webinars hosted by various lung cancer and environmental organizations to help prevent future deaths and diagnosis of radon-related lung cancer.
“My entire being is now dedicated to letting others know that simple solutions to good health are obtainable through research and education,” she said.
Nixon is the Director of Marketing & Communications for Citizens Radioactive Radon Reduction (CR3) and the Publisher of CR3 News Magazine. She is also a CR3 Pennsylvania State Representative Advocate committed to educating communities about radon, the Co-founder of the Premier Youth Ambassadors for Radon Reduction (PYA), and the developer of the CLEHR [“clear”] Network. Additionally, she holds degrees in computer technology and computer science from Edinboro University, a degree in art from the Art Institute of Pittsburgh, with 32 yrs in technology. She is the CEO of ROI Market Media LLC, established in 2010.
Memberships and affiliations include: Hillman Cancer Institute, Pennsylvania Cancer Coalition, LungCan, Cancer & Environment of So. West PA, Protect PT, PA AllofUs, National Radon Action Plan, PA-DOH COVID Response and PA-DOH HEAT Racial and Ethnic Minorities Committee. International Association for the Study of Lung Cancer (IASLC) selected Jackie as a participant for the Supportive Training for Advocates on Research and Science (STARS) Program as a Patient Research Advocate (PRA).